Acetaminophen Adduct Formation in Non-Drinkers Taking Therapeutic Doses of Acetaminophen for Ten Consecutive Days — Non-Drinker

Drug Induced Liver Injury Clinical Trial

Official title:
Acetaminophen Adduct Formation in Alcohol Abstaining Subjects Administered Therapeutic Doses of Acetaminophen for Ten Consecutive Days

Status Completed

Clinical Trial Summary

Acetaminophen is commonly used to treat fever or pain. Your body clears acetaminophen by processing it in the liver. During the processing, some of the acetaminophen may bind to proteins in the liver. The protein-acetaminophen product is called an "adduct." After a large acetaminophen overdose, the liver has to process a lot of acetaminophen, so large amounts of adducts are formed. However, we have found that lower levels may be formed even when people take recommended doses. The purpose of this study is to measure the amount of adducts formed when healthy people who do not drink alcohol take normal doses of acetaminophen for 10 days.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00616018
Study type	Interventional
Source	Denver Health and Hospital Authority
Contact
Status	Completed
Phase	Phase 4
Start date	August 2007
Completion date	January 2008

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05738681` - Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial	Phase 2/Phase 3
Completed	`NCT01000766` - Identifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver Injury	N/A
Recruiting	`NCT00360646` - Drug-Induced Liver Injury (DILI) Network Retrospective
Recruiting	`NCT05789797` - Remaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy
Terminated	`NCT02686385` - Efficacy of N-acetylcysteine With or Without Steroids in Drug Induced Liver Injury	N/A
Recruiting	`NCT06446609` - Drug-induced Liver Injury: Itching Study
Active, not recruiting	`NCT04269486` - A Multicenter Observational Study on Safety of the Herbal Medicines at Inpatient Setting
Recruiting	`NCT06192589` - Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions	Phase 1
Withdrawn	`NCT01137591` - Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever	N/A